Health Economics 1st Edition Bhattacharya Solutions Manual

Original price was: $35.00.Current price is: $26.50.

Health Economics 1st Edition Bhattacharya Solutions Manual Digital Instant Download

Category:

This is completed downloadable of Health Economics 1st Edition Bhattacharya Solutions Manual

Product Details:

  • ISBN-10 ‏ : ‎ 113702996X
  • ISBN-13 ‏ : ‎ 978-1137029966
  • Author:   Jay Bhattacharya (Author), Timothy Hyde (Contributor), Peter Tu (Contributor)

Comprehensive in coverage this textbook, written by academics from leading institutions, discusses current developments and debates in modern health economics from an international perspective. Economic models are presented in detail, complemented by real-life explanations and analysis, and discussions of the influence of such theories on policymaking. Offering sound pedagogy and economic rigor, Health Economics focuses on building intuition alongside appropriate mathematical formality, translating technical language into accessible economic narrative. Rather than shying away from intellectual building blocks, students are introduced to technical and theoretical foundations and encouraged to apply these to inform empirical studies and wider policymaking. Health Economics provides: – A broad scope, featuring comparative health policy and empirical examples from around the world to help students relate the principles of health economics to everyday life – Coverage of topical issues such as the obesity epidemic, economic epidemiology, socioeconomic health disparities, and behavioural economics – A rich learning resource, complete with hundreds of exercises to help solidify and extend understanding. This book is designed for advanced undergraduate courses in health economics and policy but may also interest postgraduate students in economics, medicine and health policy.

 

Table of Content:

  1. 1. Why health economics?
  2. 1.1 The health care economy is massive
  3. 1.2 Health is uncertain and contagious
  4. 1.3 Health economics is public finance
  5. 1.4 Welfare economics
  6. 1.5 A special note for non-American readers
  7. I: Demand for health and health care
  8. 2. Demand for health care
  9. 2.1 Experiments on the demand for health care
  10. 2.2 Is demand for health care downward-sloping?
  11. 2.3 Measuring price sensitivity with elasticities
  12. 2.4 Does the price of health care affect health?
  13. 2.5 Conclusion
  14. 2.6 Exercises
  15. 3. Demand for health: the Grossman model
  16. 3.1 A day in the life of the Grossman model
  17. 3.2 An optimal day
  18. 3.3 Extending Grossman from cradle to grave
  19. 3.4 Comparative statics
  20. 3.5 Unifying the Grossman model
  21. 3.6 Conclusion
  22. 3.7 Exercises
  23. 4. Socioeconomic disparities in health
  24. 4.1 The pervasiveness of health inequality
  25. 4.2 The Grossman model and health disparities
  26. 4.3 The efficient producer hypothesis
  27. 4.4 The thrifty phenotype hypothesis
  28. 4.5 The direct income hypothesis
  29. 4.6 The allostatic load hypothesis
  30. 4.7 The productive time hypothesis
  31. 4.8 Time preference: the Fuchs hypothesis
  32. 4.9 Conclusion
  33. 4.10 Exercises
  34. II: Supply of health care
  35. 5. The labor market for physicians
  36. 5.1 The training of physicians
  37. 5.2 Physician wages
  38. 5.3 Barriers to entry
  39. 5.4 Physician agency
  40. 5.5 Racial discrimination by physicians
  41. 5.6 Conclusion
  42. 5.7 Exercises
  43. 6. The hospital industry
  44. 6.1 The rise and decline of the modern hospital
  45. 6.2 The relationship between hospitals and physicians
  46. 6.3 The relationship between hospitals and other hospitals
  47. 6.4 Nonprofits and hospital production
  48. 6.5 The relationship between hospitals and payers
  49. 6.6 Conclusion
  50. 6.7 Exercises
  51. III: Information economics
  52. 7. Demand for insurance
  53. 7.1 Declining marginal utility of income
  54. 7.2 Uncertainty
  55. 7.3 Risk aversion
  56. 7.4 Uncertainty and insurance
  57. 7.5 Comparing insurance contracts
  58. 7.6 Conclusion
  59. 7.7 Exercises
  60. 8. Adverse selection: Akerlof’s market for lemons
  61. 8.1 The intuition behind the market for lemons
  62. 8.2 A formal statement of the Akerlof model
  63. 8.3 The adverse selection death spiral
  64. 8.4 When can the market for lemons work?
  65. 8.5 Conclusion
  66. 8.6 Exercises
  67. 9. Adverse selection: the Rothschild–Stiglitz model
  68. 9.1 The IH–IS space
  69. 9.2 Indifference curves in IH–IS space
  70. 9.3 The full-insurance line
  71. 9.4 The zero-profit line
  72. 9.5 The feasible contract wedge
  73. 9.6 Finding an equilibrium
  74. 9.7 Heterogeneous risk types
  75. 9.8 Indifference curves for the robust and the frail
  76. 9.9 Information asymmetry and the pooling equilibrium
  77. 9.10 Finding a separating equilibrium (sometimes)
  78. 9.11 Can markets solve adverse selection?
  79. 9.12 Conclusion
  80. 9.13 Exercises
  81. 10. Adverse selection in real markets
  82. 10.1 Predictions of asymmetric information models
  83. 10.2 Adverse selection in health insurance
  84. 10.3 Adverse selection in other markets
  85. 10.4 What prevents adverse selection?
  86. 10.5 Conclusion
  87. 10.6 Exercises
  88. 11. Moral hazard
  89. 11.1 What is moral hazard?
  90. 11.2 A graphical representation of moral hazard
  91. 11.3 How to limit moral hazard
  92. 11.4 Evidence of moral hazard in health insurance
  93. 11.5 The tradeoff between moral hazard and risk reduction
  94. 11.6 The upside of moral hazard?
  95. 11.7 Conclusion
  96. 11.8 Exercises
  97. IV: Economics of health innovation
  98. 12. Pharmaceuticals and the economics of innovation
  99. 12.1 The life cycle of a drug
  100. 12.2 The uncertainty and costs of drug development
  101. 12.3 Patents
  102. 12.4 Induced innovation
  103. 12.5 Regulation of the pharmaceutical industry
  104. 12.6 Conclusion
  105. 12.7 Exercises
  106. 13. Technology and the price of health care
  107. 13.1 Technology and the rise in medical expenditures
  108. 13.2 New technology and medical inflation
  109. 13.3 Technology overuse: the Dartmouth Atlas
  110. 13.4 Theories to explain the Dartmouth findings
  111. 13.5 Conclusion
  112. 13.6 Exercises
  113. 14. Health technology assessment
  114. 14.1 Cost-effectiveness analysis
  115. 14.2 Evaluating multiple treatments: the cost-effectiveness frontier
  116. 14.3 Measuring costs
  117. 14.4 Measuring effectiveness
  118. 14.5 Cost–benefit analysis: picking the optimal treatment
  119. 14.6 Valuing life
  120. 14.7 Conclusion
  121. 14.8 Exercises
  122. V: Health policy
  123. 15. The health policy conundrum
  124. 15.1 Arrow’s impossibility theorem
  125. 15.2 The health policy trilemma
  126. 15.3 How should health insurance markets work?
  127. 15.4 How should moral hazard be controlled?
  128. 15.5 How should health care provision be regulated?
  129. 15.6 Comparing national health policies
  130. 15.7 Conclusion
  131. 15.8 Exercises
  132. 16. The Beveridge model: nationalized health care
  133. 16.1 A brief tour of the Beveridge world
  134. 16.2 Rationing health care without prices
  135. 16.3 Queuing
  136. 16.4 Health technology assessment
  137. 16.5 Competition in Beveridge systems
  138. 16.6 Injecting competition
  139. 16.7 Conclusion
  140. 16.8 Exercises
  141. 17. The Bismarck model: social health insurance
  142. 17.1 A brief tour of the Bismarck world
  143. 17.2 Health insurance markets in the Bismarck model
  144. 17.3 Containing costs with price controls
  145. 17.4 Conclusion
  146. 17.5 Exercises
  147. 18. The American model
  148. 18.1 Employer-sponsored health insurance
  149. 18.2 The managed care alternative
  150. 18.3 Medicare: universal coverage for the elderly and the severely disabled
  151. 18.4 Medicaid: subsidized coverage for the poor
  152. 18.5 Uninsurance
  153. 18.6 2010 health reform
  154. 18.7 Conclusion
  155. 18.8 Exercises
  156. 19. Population aging and the future of health policy
  157. 19.1 Why is the world aging?
  158. 19.2 Health care system sustainability
  159. 19.3 Forecasting the future of health expenditures
  160. 19.4 Policy responses to population aging
  161. 19.5 Conclusion
  162. 19.6 Exercises
  163. VI: Public health economics
  164. 20. The economics of health externalities
  165. 20.1 Externalities in health
  166. 20.2 Pigouvian subsidies and taxes
  167. 20.3 The Coase theorem
  168. 20.4 The economics of organ transplantation
  169. 20.5 Conclusion
  170. 20.6 Exercises
  171. 21. Economic epidemiology
  172. 21.1 The demand for self-protection
  173. 21.2 The SIR model of infectious disease
  174. 21.3 Disease control
  175. 21.4 Applications of economic epidemiology
  176. 21.5 Conclusion
  177. 21.6 Exercises
  178. 22. Obesity
  179. 22.1 The widespread rise in obesity
  180. 22.2 What explains increasing obesity?
  181. 22.3 The costs of obesity
  182. 22.4 Is obesity a public health crisis?
  183. 22.5 Obesity contagion in social networks
  184. 22.6 Other justifications for public health intervention
  185. 22.7 Conclusion
  186. 22.8 Exercises
  187. VII: Behavioral health economics
  188. 23. Prospect theory
  189. 23.1 Modeling decisions under uncertainty
  190. 23.2 Misjudging probabilities
  191. 23.3 Framing
  192. 23.4 Loss aversion
  193. 23.5 A formal introduction to prospect theory
  194. 23.6 Implications for health economics
  195. 23.7 Conclusion
  196. 23.8 Exercises
  197. 24. Time inconsistency and health
  198. 24.1 The beta-delta discounting model
  199. 24.1 The beta-delta discounting model
  200. 24.2 Time-consistent preferences
  201. 24.3 Time-inconsistent preferences: myopia and hot brains
  202. 24.4 Demand for commitment mechanisms
  203. 24.5 Behavioral welfare economics
  204. 24.6 Conclusion
  205. 24.7 Exercises
  206. Bibliography
  207. List of figures
  208. List of tables
  209. Index